Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors Article

sustainable development goals

authors

publication date

  • April 1, 2019

webpage

published in

keywords

  • 5-Hydroxyindoleacetic acid
  • Lanreotide
  • Neuroendocrine tumor
  • Plasma chromogranin A

start page

  • 463

end page

  • 474

volume

  • 24

issue

  • 4